DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Frequency defined:   

>10% 

Antibody development 

Myalgia 

Increased creatinine phosphokinase   

<1% 

Anaphylaxis 

Pregnancy consideration: only preferred if conventional therapies do not work to treat asthma in pregnancy. 

Lactation: Reslizumab excretion in breast milk is not known.  

Pregnancy category: 

• Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester. 
• Category B: There is no evidence of risk to the fetus found in animal reproduction studies and there are not enough studies on pregnant women. 
• Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women 
• Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits. 
• Category X: Drugs listed in this category outweigh risks over benefits These category drugs should be prohibited for pregnant women. 
• Category N: There is no data available for the drug under this category. 

 

Patient information leaflet 

Generic Name: Reslizumab 

Pronounced: res-li-zu-mab  

Why do we use reslizumab? 

Reslizumab is used to treat asthma. For asthma attack use a rescue inhaler and talk with your doctor.